Documente Academic
Documente Profesional
Documente Cultură
Contact:
Bridget Hall, Communications Manager
Fujifilm Diosynth Biotechnologies
Tel : +44 (0)1642 367320
Cell: +44 (0)7796 938929
Email : bridget.hall@fujifilmdb.com
BIO : Booth # 1467
The new CBF is available to the companys customers either as part of a larger
development and manufacturing programme, or as a stand-alone service. It forms
the second stage of a major expansion of the companys mammalian cell culture
capabilities at the site, following installation last year of new process development
and scale-up capabilities. The asset will support delivery of manufacturing
programmes for both Fujifilm Diosynth Biotechnologies Billingham UK, and
Research Triangle Park, North Carolina, USA facilities.
The next stage of the companys expansion will be the commissioning of a new
cGMP manufacturing facility, also in Billingham, which is well under construction, and
due on-line in early Q4 2013. This manufacturing facility, which will primarily utilise
single-use technologies, has been designed with input from regulatory authorities
and key customers, to offer high flexibility for meeting customers needs and setting
new standards. It will initially offer 200L and 1000L single-use bioreactors, with
2000L bioreactors already planned for 2014.